The global Sickle Cell Anemia Testing and Screening Market is expected to experience significant growth over the next decade as healthcare systems worldwide strengthen early disease detection programs and improve access to advanced diagnostic technologies. “According to a recent study by SNS Insider, the global Sickle Cell Anemia Testing and Screening Market size valued at USD 494.8 million in 2025, is anticipated to grow to USD 1,579 million by 2035, registering a CAGR of 12.30% over the 2026–2035 forecast period.”
As awareness about genetic diseases grows, along with the advancement of public health screening and diagnostic technology, the management of sickle cell disease around the world is changing dramatically. More and more attention is being paid by health professionals to early diagnosis, carrier detection, and regular disease monitoring for the improvement of patients' results and proper planning of treatment.
Innovations in diagnostic technology which are able to offer speedy and precise test results will continue to improve access to testing services, not only in existing healthcare settings but also in underprivileged areas where healthcare access is limited.